Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

BACKGROUND: To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting therapy (RLAT). METHODS: This was a 24-month, multicenter, prospective, longitudinal, observational study in patients with schizophrenia who were initiated on RLAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Macfadden, Wayne, DeSouza, Cherilyn, Crivera, Concetta, Kozma, Chris M, Dirani, Riad D, Mao, Lian, Rodriguez, Stephen C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215658/
https://www.ncbi.nlm.nih.gov/pubmed/21999346
http://dx.doi.org/10.1186/1471-244X-11-167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215658/
https://www.ncbi.nlm.nih.gov/pubmed/21999346
http://dx.doi.org/10.1186/1471-244X-11-167

Ejemplares similares